Reporting on the French announcement earlier today, Bloomberg news service noted that the European Medicines Agency, which announced a review of pioglitazone in March, plans to discuss the safety of pioglitazone at its next meeting, the week of June 20, but has made no recommendations on the drug while a decision is pending.
via theheart.org
No comments:
Post a Comment